Cellular Aging Prediction via High-Content Imaging and ML
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate in defining and addressing complex, subtle, and interdependent aging phenotypes at the cellular level, which are crucial for developing effective interventions for age-related diseases.
Innovation Solution
The development of a high-content imaging system combined with machine learning algorithms to analyze morphological features of cells, identify complex aging phenotypes, and screen for drugs that can modulate aging processes, using a panel of well-characterized cells and epigenetically active molecules.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional analysis methods are used to study aging phenotypes, then the analysis process is simpler, but the ability to detect and define complex, subtle aging phenotypes is insufficient
Solution Approach 1:
The patent segments the complex task of aging phenotype detection into multiple independent components: high-content imaging captures multiple cellular parameters simultaneously, machine learning algorithms process different feature types separately, and automated procedures analyze each parameter independently before integrating results. This segmentation enables precise detection of subtle aging phenotypes while managing system complexity through modular architecture.
Solution Approach 2:
The patent transitions from conventional single-parameter analysis to multi-dimensional high-content imaging that captures morphological, textural, and compositional features across multiple channels. This dimensional expansion allows simultaneous detection of complex, subtle aging phenotypes that would be invisible in traditional single-parameter studies, resolving the contradiction between detection precision and system complexity.
2Productivity
If automated procedures are implemented for cell processing and imaging, then productivity and consistency are improved, but device complexity increases
Solution Approach 1:
The patent implements a universal automated platform that performs multiple functions: robotic cell handling, standardized staining protocols, high-content imaging, and data integration. This multi-functional system increases productivity across all processing stages while managing complexity through integrated design, where one automated system replaces multiple separate manual procedures.
Solution Approach 2:
The patent standardizes processing parameters across all automated steps, from cell seeding densities to imaging acquisition parameters. By establishing fixed, optimized parameter sets, the system achieves high throughput and consistency without requiring complex real-time adjustments, resolving the contradiction between productivity and system complexity.
3Measurement precision
If machine learning algorithms are used to identify aging phenotypes, then measurement precision and phenotype definition are improved, but the difficulty of detecting and measuring increases
Solution Approach 1:
The patent introduces machine learning algorithms as intermediaries between raw imaging data and aging phenotype interpretation. These algorithms automatically extract and integrate multiple imaging features, transforming complex multi-dimensional data into precise age predictions. This intermediary layer handles the analytical complexity while delivering simplified, accurate measurements of cellular aging phenotypes.
Solution Approach 2:
The patent creates comprehensive digital representations (morphological profiles) of cells through high-content imaging and machine learning analysis. These digital copies capture all relevant morphological features without requiring physical manipulation or complex measurement procedures, enabling precise aging phenotype detection while simplifying the actual measurement process through computational analysis.
4Adaptability or versatility
If high-content imaging and machine learning are implemented, then the ability to discover complex phenotypes and screen drugs is improved, but loss of time and resources increases
Solution Approach 1:
The patent performs preliminary action by pre-training machine learning models on large datasets of cellular images with known ages. This pre-trained model can then be rapidly applied to screen drug libraries without requiring extensive retraining or optimization for each new experiment. The preliminary computational work enables fast, versatile drug screening while minimizing time loss during actual screening campaigns.
Solution Approach 2:
The patent implements continuous automated processing where robotic cell handling, imaging, and machine learning analysis operate in an integrated pipeline without manual intervention. This continuous operation maximizes productivity and enables rapid screening of large drug libraries, offsetting the initial time investment through sustained high-speed processing and automated data analysis.
Data Source
AI summary
The present disclosure provides automated methods and systems for implementing an aging analysis pipeline involving the training and deployment of a predictive model for predicting cellular ages of cells. Such a predictive model distinguishes between morphological cellular phenotypes e.g., morphological cellular phenotypes elucidated using Cell Paint, exhibited by cells of different ages. The predictive model is further useful for developing new cellular aging assays that include biomarkers that heavily contribute towards predictions of the predictive model. Furthermore, the predictive model is useful for screening drug candidates for their ability to alter or suppress age related phenotypes.